CD247 and non-Hodgkin lymphoma: treated 6 patients with relapsed non-Hodgkin’s lymphoma who were simultaneously infused with a “first generation” CAR T product harboring only a CD3ζ endodomain and a “second generation” CAR T product harboring both CD3ζ and CD28 endodomains (29).